Allan Santiago

NPI: 1457327306
Total Payments
$3,917
2024 Payments
$50.00
Companies
10
Transactions
36
Medicare Patients
344
Medicare Billing
$29,627

Payment Breakdown by Category

Food & Beverage$2,961 (75.6%)
Travel$867.02 (22.1%)
Education$89.00 (2.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,961 32 75.6%
Travel and Lodging $867.02 3 22.1%
Education $89.00 1 2.3%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $2,443 10 $0 (2017)
E.R. Squibb & Sons, L.L.C. $457.67 10 $0 (2024)
AbbVie Inc. $302.59 6 $0 (2023)
Gilead Sciences, Inc. $242.32 4 $0 (2021)
GENZYME CORPORATION $139.70 1 $0 (2023)
PFIZER PHARMACEUTICALS LLC $125.00 1 $0 (2019)
Janssen Biotech, Inc. $89.00 1 $0 (2021)
Merck Sharp & Dohme Corporation $76.97 1 $0 (2017)
PBG PUERTO RICO LLC $24.61 1 $0 (2021)
Janssen Pharmaceuticals, Inc $15.92 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $50.00 2 E.R. Squibb & Sons, L.L.C. ($50.00)
2023 $235.89 5 GENZYME CORPORATION ($139.70)
2022 $141.66 3 E.R. Squibb & Sons, L.L.C. ($122.21)
2021 $392.85 8 E.R. Squibb & Sons, L.L.C. ($214.27)
2019 $256.94 3 PFIZER PHARMACEUTICALS LLC ($125.00)
2018 $123.39 2 Gilead Sciences, Inc. ($101.19)
2017 $2,716 13 Allergan Inc. ($2,443)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/24/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Neuroscience
01/31/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Neuroscience
12/06/2023 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Neuroscience
08/31/2023 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Neuroscience
07/05/2023 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $21.19 General
Category: Neuroscience
05/25/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $139.70 General
02/27/2023 AbbVie Inc. MAVYRET (Drug) Food and Beverage In-kind items and services $25.00 General
Category: VIROLOGY
12/07/2022 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $101.88 General
Category: Neuroscience
04/21/2022 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $19.45 General
Category: VIROLOGY
03/11/2022 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $20.33 General
Category: Neuroscience
12/15/2021 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $112.65 General
Category: Neuroscience
12/07/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.61 General
09/01/2021 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $79.12 General
Category: Neuroscience
08/12/2021 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $22.50 General
Category: Neuroscience
07/06/2021 Janssen Biotech, Inc. STELARA (Biological) Education In-kind items and services $89.00 General
Category: Immunology
06/04/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.46 General
05/06/2021 AbbVie Inc. MAVYRET (Drug) Food and Beverage In-kind items and services $23.90 General
Category: VIROLOGY
04/30/2021 PBG PUERTO RICO LLC XELJANZ (Drug) Food and Beverage In-kind items and services $24.61 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/01/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA, PREZCOBIX Food and Beverage In-kind items and services $15.92 General
Category: Cardiovascular & Metabolism
04/04/2019 PFIZER PHARMACEUTICALS LLC XELJANZ (Drug) Food and Beverage In-kind items and services $125.00 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
03/21/2019 AbbVie, Inc. Mavyret (Drug) Food and Beverage In-kind items and services $116.02 General
Category: Virology
09/28/2018 AbbVie, Inc. Food and Beverage In-kind items and services $22.20 General
07/18/2018 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $101.19 General
Category: HCV
08/17/2017 Gilead Sciences Inc Epclusa (Drug) Food and Beverage In-kind items and services $100.06 General
Category: HCV
05/19/2017 Allergan Inc. Food and Beverage In-kind items and services $595.20 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 104 128 $14,552 $10,632
2022 3 91 117 $10,709 $6,916
2021 3 75 104 $9,626 $6,914
2020 3 74 97 $7,565 $5,165
Total Patients
344
Total Services
446
Medicare Billing
$29,627
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 64 $5,816 $4,202 72.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Office 2023 12 12 $4,611 $3,527 76.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 21 21 $2,370 $1,528 64.5%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Office 2023 29 31 $1,756 $1,375 78.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 41 65 $6,003 $4,010 66.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 30 30 $3,426 $1,893 55.3%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Office 2022 20 22 $1,281 $1,012 79.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 36 64 $5,937 $4,216 71.0%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 24 24 $2,738 $1,937 70.8%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Office 2021 15 16 $950.40 $760.32 80.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 42 63 $4,813 $3,323 69.0%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 15 15 $1,647 $964.09 58.5%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Office 2020 17 19 $1,105 $878.49 79.5%

About Allan Santiago

Allan Santiago is a Gastroenterology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457327306.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allan Santiago has received a total of $3,917 in payments from pharmaceutical and medical device companies, with $50.00 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,961).

As a Medicare-enrolled provider, Santiago has provided services to 344 Medicare beneficiaries, totaling 446 services with total Medicare billing of $29,627. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location San Juan, PR
  • Active Since 02/28/2006
  • Last Updated 01/22/2014
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1457327306

Products in Payments

  • ZEPOSIA (Drug) $457.67
  • Epclusa (Drug) $201.25
  • XELJANZ (Drug) $149.61
  • Mavyret (Drug) $116.02
  • Humira (Biological) $96.02
  • STELARA (Biological) $89.00
  • ZEPATIER (Drug) $76.97
  • MAVYRET (Drug) $68.35
  • XARELTO (Drug) $15.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in San Juan